Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 8/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 7/20 | 0.40 |
| ▸ | CA7 | P43166 | 3/20 | 0.40 |
| ▸ | CA13 | Q8N1Q1 | 2/20 | 0.40 |
| ▸ | CA9 | Q16790 | 6/20 | 0.35 |
| ▸ | CA12 | O43570 | 4/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | ATR | Q13535 | 1/20 | 0.33 |
| ▸ | CA5A | P35218 | 3/20 | 0.32 |
| ▸ | CA4 | P22748 | 2/20 | 0.32 |
| ▸ | CA6 | P23280 | 2/20 | 0.32 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.32 |
| ▸ | NT5E | P21589 | 1/20 | 0.32 |
| ▸ | NOS1 | P29475 | 1/20 | 0.32 |
| ▸ | NOS2 | P35228 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | CA3 | P07451 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL30657138 | 1.00 | CA1 (0.47) | CA1ALDH1A1L3MBTL1CA2CA7 | |
| Trifluoroacetic Acid SCHEMBL30605511 | 0.88 | ALDH1A1 (0.48) | CA1ALDH1A1L3MBTL1CA2CA7 | |
| Trifluoroacetic Acid SCHEMBL144167 | 0.85 | ALDH1A1 (0.52) | CA1ALDH1A1L3MBTL1CA2CA7 | |
| Trifluoroacetic Acid SCHEMBL28219947 | 0.83 | ALDH1A1 (0.40) | CA1ALDH1A1L3MBTL1CA2CA7 | |
| Trifluoroacetic Acid SCHEMBL28849341 | 0.82 | ALDH1A1 (0.50) | CA1ALDH1A1L3MBTL1CA2CA7 | |
| Trifluoromethanesulfonamide SCHEMBL2333486 | 0.82 | CA1 (0.65) | CA1ALDH1A1L3MBTL1CA2CA7 | |
| Trifluoroacetic Acid SCHEMBL21632604 | 0.82 | ALDH1A1 (0.50) | CA1ALDH1A1L3MBTL1CA2CA7 | |
| Trifluoroacetic Acid SCHEMBL1731636 | 0.81 | — | — | |
| Trifluoroacetic Acid SCHEMBL29615579 | 0.81 | ALDH1A1 (0.41) | ALDH1A1L3MBTL1CA2TSHRNOS1 | |
| Trifluoroacetic Acid SCHEMBL5245971 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106941019-A | Electric conductor, its manufacture method and the electronic installation including it | 三星电子株式会社 | 2017-07-11 | — | — | CN | claimed |
| WO-2025081019-A1 | KIF MODULATOR COMPOUNDS AND METHODS OF USE | IAMBIC THERAPEUTICS, INC. (US) | 2025-04-17 | — | — | WO | disclosed |
| CN-119585252-A | Bicyclic heteroaryl containing compounds as IKZF2 degrading agents | 翁科皮亚治疗公司和SK生命科学实验室 | 2025-03-07 | — | — | CN | disclosed |
| WO-2024227104-A1 | BIFUNCTIONAL COMPOUNDS FOR DEGRADING BRAF VIA UBIQUITIN PROTEOSOME PATHWAY | NURIX THERAPEUTICS, INC. (US) | 2024-10-31 | — | — | WO | disclosed |
| CN-118005640-A | GCN2 inhibitors and uses thereof | 默克专利股份有限公司 | 2024-05-10 | — | — | CN | disclosed |
| CN-111918651-B | GCN2 inhibitors and uses thereof | 默克专利股份有限公司 | 2024-01-30 | — | — | CN | disclosed |
| CN-116848091-A | Inhibitors of ectonucleotide pyrophosphatase-phosphodiesterase-1 (ENPP 1) and uses thereof | 1CBIO公司 | 2023-10-03 | — | — | CN | disclosed |
| WO-2023174406-A1 | NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF | 上海翰森生物医药科技有限公司 | 2023-09-21 | — | — | WO | disclosed |
| US-20230266321-A1 | LIVE CELL ENGAGEMENT ASSAY | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 2023-08-24 | — | — | US | disclosed |
| CN-116323624-A | Quinazoline compound and application thereof | 上海医药集团股份有限公司 | 2023-06-23 | — | — | CN | disclosed |
| WO-2022068921-A1 | QUINAZOLINE COMPOUND AND APPLICATION THEREOF | 上海医药集团股份有限公司 | 2022-04-07 | — | — | WO | disclosed |
| CN-105339332-B | Cycloalkanes oxidation catalyst and the method for production alcohol and ketone | 罗地亚经营管理公司 | 2018-04-10 | — | — | CN | disclosed |
| CN-105339332-B | Cycloalkanes oxidation catalyst and the method for production alcohol and ketone | 罗地亚经营管理公司 | 2018-04-10 | — | — | CN | disclosed |
| US-9761532-B2 | Hybrid interconnect structure and electronic device employing the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-09-12 | — | — | US | disclosed |
| CN-106941019-A | Electric conductor, its manufacture method and the electronic installation including it | 三星电子株式会社 | 2017-07-11 | — | — | CN | disclosed |
| US-20170092592-A1 | HYBRID INTERCONNECT STRUCTURE AND ELECTRONIC DEVICE EMPLOYING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-03-30 | — | — | US | disclosed |
| CN-105339332-A | Cycloalkane oxidation catalysts and method to produce alcohols and ketones | RHODIA OPERATIONS | 2016-02-17 | — | — | CN | disclosed |
| EP-2054053-A1 | BIPHENYL SUBSTITUTED SPIROTETRONIC ACIDS AND THEIR USE FOR THE TREATMENT OF RETROVIRAL DISORDERS | AiCuris GmbH & Co. KG (DE) | 2009-05-06 | — | — | EP | disclosed |
| WO-2008022725-A1 | BIPHENYL SUBSTITUTED SPIROTETRONIC ACIDS AND THEIR USE FOR THE TREATMENT OF RETROVIRAL DISORDERS | AICURIS GMBH & CO. KG (DE) | 2008-02-28 | — | — | WO | disclosed |
| WO-2005004796-A2 | SULFONYLAMINO PHENYLACETAMIDE DERIVATIVES AND METHODS OF THEIR USE | ADOLOR CORPORATION (US) | 2005-01-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230266321-A1 | LIVE CELL ENGAGEMENT ASSAY | KSR1, KSR2, ARAF | CA1 4506/4885ALDH1A1 4413/4885L3MBTL1 1077/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.